BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinsons disease
Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at…
Aptos Experience 2025 Kicks Off in New York City on October 15-16
Two Days of Breakthrough Innovation, Bold Ideas, and Real-World Connections NEW YORK,…
NYSE Content Advisory: Pre-Market Update + S&P 500 comes off 1.1% weekly gain
NEW YORK, Oct. 6, 2025 /PRNewswire/ -- The New York Stock Exchange…
Biz2X Collaborates with AWS to Launch Industry-First Agentic AI Digital Lending Solution
Conversational AI capabilities will empower lenders to increase lending volumes by up…
Talos Integrates OEMS with BlackRock’s Aladdin Platform to Expand Institutional Digital Asset Order Management Capabilities
New integration unlocks greater efficiency for BlackRock's trading team, realizing over $1…
DATROWAY Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival as First-Line Therapy for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02
Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only therapy to…
GITEX 2025 Spotlight: iFLYTEK Strengthens Ties with the Middle East to Drive Digital Transformation
DUBAI, United Arab Emirates--(BUSINESS WIRE)--As AI reshapes industries worldwide, the Middle East…
Bybit Upgrades Convert Features with Exclusive Lucky Draw
DUBAI, UAE, Oct. 1, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange…
1inch rebrands to reflect broader mission uniting DeFi and global finance
1inch's design, messaging and product strategy aim to better reflect the platform's…
oneZero appoints Asiff Hirji, Former Coinbase & Ameritrade President, to Board of Directors
SOMERVILLE, Mass., Oct. 1, 2025 /PRNewswire/ -- oneZero, a leading provider of…